9 hours ago
Description
(AWP Alliance News) - MindMaze Therapeutics on Oct. 14, 2026 reported real-world results from a multi-site home-based neurorehabilitation program, with the findings already presented at the American Congress of Rehabilitation Medicine. The program showed that using its MindMotion system at home increased overall rehabilitation activity versus standard outpatient care, with most sessions completed without direct therapist supervision.
Patients also posted broad functional gains across everyday independence, mobility, balance, and cognition, alongside high satisfaction. The results support MindMaze's push to extend higher-intensity therapy beyond clinics ahead of its planned year-end 2026 launch of MindMotion Lite, a tablet-based version designed to simplify home deployment.
https://www.publicnow.com/view/27DC48D94BCCE34F0BAB2902480705C82747C19D…
Disclaimer: This news brief was created using generative artificial intelligence. MindMaze Therapeutics Holding SA published the original content used to generate this news brief via EQS News on October 14, 2026, and is solely responsible for the information contained therein.
